As featured in
Claim pageClaim
Follow
Overview
Connections
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Shrug Capital
Momentum
15/100
in the news
Last sign of life
1 mo ago
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Hacker News stories
3
best: 21 points
Backed byfrom the funds' portfolios and accelerator catalogs
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors

Shrug CapitalVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Nucleus Genomics' 'Have Your Best Baby' ads are back, now with IVF doctors
More than a dozen physicians appear in outdoor ads in five cities, extending last year's provocative NYC campaign.
Read more
Report
Nucleus Genomics Wants to Base Edit Embryos, Reviving Ethics Concerns
The firm has a long-term ambition to edit genes within embryos as part of its IVF services and is funding preclinical research into the technology.
Read more
Report
Southern California Reproductive Center Joins Nucleus IVF+ Network as Patient Demand Accelerates
SCRC, a leading Californian fertility center, is partnering with Nucleus to bring advanced genetic analysis to thousands of patients annually....
Read more
Report
Nucleus Brings Genetic Optimization to India and the Middle East Through Leading IVF Networks
Nucleus announces joint ventures with Indira IVF and the Abu Ghosh Fertility Group, bringing their advanced genetic screening to India and the Middle...
Read more
Report
Nucleus Upgrades Preview, The First True Glimpse of Your Future Child
Nucleus Preview is a new preconception test for couples that combines rare and chronic disease screening with trait modeling for the first time ever....
Read more
Report
Embryo scoring: 10 Breakthrough Technologies 2026
Genetic testing on embryos is more sophisticated and accessible than ever-and it's now being sold as a way to let parents pick their future baby's best traits.
Read more
Report
You might hate these companies' ads. That's the point.
Corporate marketers are embracing a strategy perfected by online influencers: Stoke rage and watch the attention roll in.
Read more
Report
Fertility startup that screens embryos to predict height, intelligence and disease sparks debate with 'great genes' campaign
A fertility startup that offers embryo screening to predict a baby's height and intelligence has sparked backlash with a series of provocative new ads. Nucleus Genomics blanketed Big Apple subway stations with billboards this week as part of their "Have Y
Read more
Report
Report
Report
Show more news
